Purpose: To investigate the association of prostate blood flow (PBF) with lower urinary tract symptoms (LUTS) in aged males using Doppler spectral waveform (DSW) analysis. Patients and Methods: We performed a prospective analysis involving 133 aged males with clinical diagnosis of LUTS. DSW parameters (peak-systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI)) were measured at bilateral neurovascular bundles (NVB), periurethral, and capsular branches by Doppler transrectal ultrasound with the patient in the right lateral decubitus position. The associations of PBF parameters and the International Prostate Symptom Score (IPSS) were analyzed. Results: Overall, total IPSS scores were significantly correlated with the RI of bilateral NVB vessels (r2 = 0.03, 0.04; p = 0.04, 0.02, respectively), and PSV of left NVB vessels. PSV of bilateral NVB vessels were associated with the storage score (p = 0.022 and p = 0.016), but not with the voiding score. The sum of the frequency and urgency score was also associated with EDV of both capsular and urethral branches (p = 0.043 and p = 0.009, respectively), and PSV of NVB vessels on both sides (p = 0.045 and p = 0.019, respectively). Conclusions: There is an association between PBF and LUTS, especially with storage symptoms. The findings may provide some insights in understanding the underlying pathophysiology of lower urinary tract dysfunction.

Keywords:
Lower urinary tract symptom, Doppler ultrasound imagings, Prostate, Benign prostatic hyperplasia
1.
Abrams P: New words for old: lower urinary tract symptoms for ‘prostatism'. BMJ 1994;308:929-930.
2.
Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-1314; discussion 1314-1315.
3.
Zhang L, Zhu L, Xu T, Lang J, Li Z, Gong J, Liu Q, Liu X: A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women. Eur Urol 2015;68:97-112.
4.
Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J: Evaluation and treatment of lower urinary tract symptoms in older men. J Urol 2009;181:1779-1787.
5.
Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT, Roehrborn CG: Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol 2008;54:563-569.
6.
Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KA, Gravas S: EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015;67:1099-1109.
7.
Gibbons EP, Colen J, Nelson JB, Benoit RM: Correlation between risk factors for vascular disease and the American urological association symptom score. BJU Int 2007;99:97-100.
8.
Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT: The American urological association symptom index for benign prostatic hyperplasia. The measurement committee of the American urological association. J Urol 1992;148:1549-1557; discussion 1564.
9.
Chen IH, Tsai YS, Tong YC: Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia. Urology 2012;79:409-414.
10.
Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, Miki T: Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Eur Urol 2000;37:436-442.
11.
Shinbo H, Kurita Y, Takada S, Imanishi T, Otsuka A, Furuse H, Nakanishi T, Mugiya S, Ozono S: Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia. Urology 2010;76:1440-1445.
12.
Shinbo H, Kurita Y, Nakanishi T, Imanishi T, Otsuka A, Furuse H, Mugiya S, Ozono S: Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia. Urology 2010;75:143-147.
13.
Wein AJ, Rovner ES: Definition and epidemiology of overactive bladder. Urology 2002;60(5 suppl 1):7-12; discussion 12.
14.
Hampel C, Gillitzer R, Pahernik S, Hohenfellner M, Thüroff JW: [Epidemiology and etiology of overactive bladder]. Urologe A 2003;42:776-786.
15.
Christiaansen CE, Sun Y, Hsu YC, Chai TC: Alterations in expression of HIF-1α, HIF-2α, and VEGF by idiopathic overactive bladder urothelial cells during stretch suggest role for hypoxia. Urology 2011;77:1266.e7-e11.
16.
Azadzoi KM, Yalla SV, Siroky MB: Oxidative stress and neurodegeneration in the ischemic overactive bladder. J Urol 2007;178:710-715.
17.
Camões J, Coelho A, Castro-Diaz D, Cruz F: Lower urinary tract symptoms and aging: the impact of chronic bladder ischemia on overactive bladder syndrome. Urol Int 2015;95:373-379.
18.
Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I: Normal prostate gland: examination with color Doppler US. Radiology 1995;196:453-457.
19.
Alexandrov AV, Brodie DS, McLean A, Hamilton P, Murphy J, Burns PN: Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. Stroke 1997;28:339-342.
20.
Spencer MP, Reid JM: Quantitation of carotid stenosis with continuous-wave (C-W) Doppler ultrasound. Stroke 1979;10:326-330.
21.
Berger AP, Bartsch G, Deibl M, Alber H, Pachinger O, Fritsche G, Rantner B, Fraedrich G, Pallwein L, Aigner F, Horninger W, Frauscher F: Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int 2006;98:1038-1042.
22.
Azadzoi KM, Babayan RK, Kozlowski R, Siroky MB: Chronic ischemia increases prostatic smooth muscle contraction in the rabbit. J Urol 2003;170(2 pt 1):659-663.
23.
Tsai YS, Jou YC, Chen CH, Chang CC, Yang WH, Lai JL, Tzai TS: Doppler spectral waveform parameters at neurovascular bundle vessels in patients with prostate biopsy. J Endourol 2014;28:364-370.
24.
Halpern EJ, Frauscher F, Forsberg F, Strup SE, Nazarian LN, O'Kane P, Gomella LG: High-frequency Doppler US of the prostate: effect of patient position. Radiology 2002;222:634-639.
25.
Russo GI, Kurbatov D, Sansalone S, Lepetukhin A, Dubsky S, Sitkin I, et al: Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities. Urology 2015;86:343-348.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.